Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure - BioVAT-HF-DZHK20

Presented During:

Monday, May 4, 2026: 9:00AM - 4:00PM
McCormick Place Lakeside Center  
Posted Room Name: Exhibit Hall, Poster Area  

Abstract No:

LB008 

Submission Type:

Late-Breaking Clinical Trial Abstract 

Authors:

Stephan Ensminger (1), Ingo Kutschka (2), Ahmad-Fawad Jebran (2), Christina Paitazoglou (3), Sören Brandenburg (2), Malte Tiburcy (2), Buntaro Fujita (3), Tobias Legler (2), Thomas Puehler (3), Joachim Lotz (2), Monika Sadlonova (2), Tim Friede (2), Wolfram Zimmermann (2)

Institutions:

(1) University Heart Center Lübeck, Luebeck, Germany, (2) University Medical Center Göttingen, Göttingen, Germany, (3) University Heart Center Lübeck, Lübeck, Germany

Submitting Author:

*Stephan Ensminger    -  Contact Me
University Heart Center Lübeck

Co-Author(s):

Ingo Kutschka    -  Contact Me
University Medical Center Göttingen
Ahmad-Fawad Jebran    -  Contact Me
University Medical Center Göttingen
Christina Paitazoglou    -  Contact Me
University Heart Center Lübeck
Sören Brandenburg    -  Contact Me
University Medical Center Göttingen
Malte Tiburcy    -  Contact Me
University Medical Center Göttingen
Buntaro Fujita    -  Contact Me
University Heart Center Lübeck
Tobias Legler    -  Contact Me
University Medical Center Göttingen
Thomas Puehler    -  Contact Me
University Heart Center Lübeck
Joachim Lotz    -  Contact Me
University Medical Center Göttingen
Monika Sadlonova    -  Contact Me
University Medical Center Göttingen
Tim Friede    -  Contact Me
University Medical Center Göttingen
Wolfram Zimmermann    -  Contact Me
University Medical Center Göttingen

Presenting Author:

*Stephan Ensminger    -  Contact Me
Department of Cardiac and Thoracic Vascular Surgery

Abstract:

This abstract will become available at the time of presentation.

Category:

Adult Cardiac

Keywords - Adult

Transplant - Transplant